2022
DOI: 10.1016/j.jep.2021.114791
|View full text |Cite
|
Sign up to set email alerts
|

Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-κB and MAPK signaling pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(21 citation statements)
references
References 43 publications
1
20
0
Order By: Relevance
“…Plausibly, products from hydrolysis and metabolism, such as GA, EA, and UroA, participate in the biological effect, although their formation at the gut level has rarely been addressed. This evidence is supported by several in vivo experiments, in which HTs and metabolites were administered as individual compounds through the oral route at comparable doses: EA (50 mg/kg) ameliorated the inflammatory profile in RA models [ 31 , 32 , 33 , 34 , 35 ]; similarly EA, GA, and UroA (10–20 mg/kg) inhibited gut inflammation in IBD models [ 64 , 65 , 66 , 70 , 71 , 72 ], while EA (10 mg/kg) and GA (20–80 mg/kg) reduced allergic inflammation in AD, asthma, and rhinitis [ 86 , 88 , 96 , 102 ]. Remarkably, HTs have frequently been mentioned for direct antibacterial and antiviral activity [ 106 ], which may suggest a restrained impact on infection risk.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…Plausibly, products from hydrolysis and metabolism, such as GA, EA, and UroA, participate in the biological effect, although their formation at the gut level has rarely been addressed. This evidence is supported by several in vivo experiments, in which HTs and metabolites were administered as individual compounds through the oral route at comparable doses: EA (50 mg/kg) ameliorated the inflammatory profile in RA models [ 31 , 32 , 33 , 34 , 35 ]; similarly EA, GA, and UroA (10–20 mg/kg) inhibited gut inflammation in IBD models [ 64 , 65 , 66 , 70 , 71 , 72 ], while EA (10 mg/kg) and GA (20–80 mg/kg) reduced allergic inflammation in AD, asthma, and rhinitis [ 86 , 88 , 96 , 102 ]. Remarkably, HTs have frequently been mentioned for direct antibacterial and antiviral activity [ 106 ], which may suggest a restrained impact on infection risk.…”
Section: Discussionmentioning
confidence: 69%
“…The in vivo results showed that corilagin significantly reduced paw swelling and arthritis score and inhibited joint erosion and the infiltration of inflammatory cells; pro-inflammatory cytokines were also inhibited at the serum level (IL-6, TNF-α, IL-1β, and IL-17). In fibroblast-like synoviocyte (FLS) cells challenged by IL-1β, corilagin (6.25 or 12.5 μM) impaired COX-2, iNOS, and MMPs expression through MAPKs and NF-κB inhibition [ 32 ].…”
Section: Resultsmentioning
confidence: 99%
“…The Mitogen-activated protein kinase kinase (MEK)/ Extracellular signal-regulated kinase (ERK) signaling cascades are important for inflammatory progression in RA (32,33). We, therefore, sought to determine whether Antcin K affects MEK and ERK signaling.…”
Section: Antcin K Inhibits Vcam-1 Synthesis By Suppressing Mek1/2-erk...mentioning
confidence: 99%
“…4b-e and 5be). The p38 signaling pathway is involved in the regulation of CAM and proinflammatory cytokine expression during RA development (33,34). We, therefore, investigated whether Antcin K inhibits VCAM-1 expression and monocyte adhesion in RASFs via the p38 signaling pathway.…”
Section: Antcin K Inhibits Vcam-1 Synthesis By Suppressing Mek1/2-erk...mentioning
confidence: 99%
“…TNF-α triggers NF-κB activation by a variety of signaling molecules, including TRAF2 (TNF receptor-associated factor 2), RIP (receptor-interacting protein), and the IKK (IκB kinase) complex. Another signal pathway activated by TNF-α is mitogen-activated protein kinase pathways (including p38, JNK, and ERK1/2), which has been strongly associated with many of the processes that mediate the pathological features of RA [7]. The p38 MAPK and JNK (Jun N-terminal kinase) pathway inhibitors attract more attention since they can reduce both the synthesis of proinflammatory cytokine and their intracellular signaling [8].…”
Section: Introductionmentioning
confidence: 99%